相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single β-lactams versus combinations as empiric therapy for infections with Pseudomonas aeruginosa: assessing the in vitro susceptibility
Safa S. Almarzoky Abuhussain et al.
INFECTIOUS DISEASES (2020)
Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin
Wonhee So et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
A Combination Antibiogram Evaluation for Pseudomonas aeruginosa in Respiratory and Blood Sources from Intensive Care Unit (ICU) and Non-ICU Settings in US Hospitals
Laura Puzniak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model
Marguerite L. Monogue et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals
Mariana Castanheira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Clinical relevance of in vitro synergistic activity of antibiotics for multidrug-resistant Gram-negative infections: A systematic review
Konstantinos Z. Vardakas et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)
Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens
Kenneth S. Thomson et al.
ANTIBIOTICS-BASEL (2019)
Feasibility of routine synergy testing using antibiotic gradient diffusion strips in the clinical laboratory
Lindsay M. Avery et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactann Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234
Krisztina M. Papp-Wallace et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases
Helio S. Soder et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Potency of parenteral antimicrobials including ceftolozane/tazobactam against nosocomial respiratory tract pathogens: considerations for empiric and directed therapy
Christina A. Sutherland et al.
JOURNAL OF THORACIC DISEASE (2017)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil et al.
CLINICAL INFECTIOUS DISEASES (2016)
Is double coverage of gram-negative organisms necessary?
Sarah J. Johnson et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2011)
分享论文
